Cyclerion Therapeutics, Inc. - Common Stock — Statistiques financières trimestrielles (NASDAQ:CYCN) | MetaTrader

Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques

Trimestriel Annuel

Flux de trésorerie liés aux activités d'exploitation 360 K-968 K-503 K-264 K-1.58 M-1.18 M -3.52 M Flux de trésorerie liés aux activités d'investissement 0————-66 K — Flux de trésorerie liés aux activités de financement 01.38 M-130 K1.83 M251 K825 K 2.77 M Flux de trésorerie disponible 360 K-968 K-503 K-264 K-1.58 M-1.24 M -3.59 M

Nouvelles

Deal Dispatch: McCormick, Unilever Fusion, Sysco Acquiert Jetro Restaurant Depot Pour 29 Milliards de Dollars, QVC Envisage la Faillite | Benzinga France

Globalstar, Exxon Mobil, Cyclerion Therapeutics, Eli Lilly And Intel: Why These 5 Stocks Are On Investors

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.48%

Cyclerion Therapeutics, Inc. (CYCN) M&A Call Prepared Remarks Transcript

Cyclerion receives FDA feedback on depression treatment development

Why AZZ Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Acrivon Therapeutics (NASDAQ:ACRV), AZZ (NYSE:AZZ)

Cyclerion Therapeutics, Inc. (CYCN) Discusses Medsteer Development Collaboration and Updates on Phase 2 Proof-of-Concept Study in Treatment-Resistant Depression - Slideshow (NASDAQ:CYCN) 2026-01-07

Cyclerion Therapeutics, Inc. (CYCN) Discusses Medsteer Development Collaboration and Updates on Phase 2 Proof-of-Concept Study in Treatment-Resistant Depression Prepared Remarks Transcript

Dow Jumps Over 400 Points; US Services Activity Falls In December - Aeva Technologies (NASDAQ:AEVA), Alumis (NASDAQ:ALMS)

US Stocks Mixed; Nasdaq Gains Over 50 Points - Alumis (NASDAQ:ALMS), AngioDynamics (NASDAQ:ANGO)

Why Cyclerion Therapeutics Shares Are Trading Higher By 44%; Here Are 20 Stocks Moving Premarket - Aeva Technologies (NASDAQ:AEVA), Alumis (NASDAQ:ALMS)

Le titre de Cyclerion Therapeutics s’envole après une collaboration stratégique avec Medsteer